Biotech · Private company
GigaGen, Inc.
Track this companyFree. Adds GigaGen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GIGA-2050Phase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- GIGA-2339Phase 1 · Hepatitis B Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- GIGA-564Phase 1 · Advanced or Metastatic Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus InfectionPHASE1 · RECRUITING · started Nov 13, 2024ClinicalTrials.gov NCT07024641 · fetched Nov 12, 2026
- A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesPHASE1 · RECRUITING · started May 8, 2024ClinicalTrials.gov NCT06258304 · fetched Nov 12, 2026
- Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 PatientsPHASE1 · TERMINATED · started May 24, 2021ClinicalTrials.gov NCT04883138 · fetched Nov 12, 2026